About Zevacor
Zevacor is a Healthcare company based in Dulles (United States) founded in 2013, and was acquired by Curium in March 2020. Radiolabeling radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging. Its focus areas include Diversified Diagnostics, Biopharma Outsourcing, CRO and Diversified. Its competitors include ImaginAb, BioTelemetry and Innovate Biopharma; 2 of its 3 listed competitors have raised funding.
Company details
Zevacor is focussed on developing radiopharmaceutical products and supporting services for use in nuclear medicine and molecular imaging. It provides its services through its subsidiaries Zevacor Pharma and Zevacor Molecular formerly IBA Molecular). Zevacor Molecular manufactures PET and SPECT radiopharmaceuticals and is working on the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes. Zevacor Pharma provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide for the development of the next generation of molecular imaging and therapeutic products.
- Headquarters Dulles, United States
- Stage Acquired
- SectorsHealthcare
- Website zevacor.com
- Social LinkedIn X Facebook
- Acquired by Curium (Mar 2020)
Investors in Zevacor
Zevacor has secured backing from 2 investors. Prominent investors backing the company include SOFIE and Curium Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Curium Pharma is recognized as a leader in radiopharmaceuticals. | 2017 | curiumpharma.com | Paris, France | |
Developer of molecular imaging systems and radio-pharmaceuticals | 2008 | sofie.com | Culver City, United States |
Investor details for Zevacor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Zevacor
3 people are tracked at Zevacor (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Trevor Subero | Senior Director Business Development | Leadership |
Renaud Dehareng | CEO | Leadership |
John Capozzi | Clinical Sales Associate | Team |
Complete people profiles for Zevacor
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Zevacor
Zevacor has 3 listed competitors in our database, 2 of them funded. They include ImaginAb, BioTelemetry and Innovate Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imaginab.com | 2007 | Los Angeles, United States | $59.64M | 17 | ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | |
| gobio.com | 1994 | Malvern, United States | 1,782 | Wireless products for monitoring health parameters are offered. | ||
| innovatebiopharma.com | 2012 | Raleigh, United States | $48.58M | Small molecule drugs and imaging agent for GI disorders |
Detailed competitors of Zevacor
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as Zevacor (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zevacor
Complete news archive for Zevacor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zevacor
Zevacor was founded in 2013.
Zevacor is headquartered in Dulles, United States. It is registered at Dulles, Virginia, United States.
Zevacor is focussed on developing radiopharmaceutical products and supporting services for use in nuclear medicine and molecular imaging. It provides its services through its subsidiaries Zevacor Pharma and Zevacor Molecular formerly IBA Molecular). Zevacor Molecular manufactures PET and SPECT radiopharmaceuticals and is working on the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes. Zevacor Pharma provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide for the development of the next generation of molecular imaging and therapeutic products.
Zevacor's top competitors include ImaginAb, BioTelemetry and Innovate Biopharma.
Zevacor has 2 investors. Key investors include SOFIE, and Curium Pharma.
Yes. Zevacor was acquired by Curium in March 2020.